Bio-fluorine Biological production of novel organofluorines via terpene biosynthesis and S.cerevisiae engineering
- Coordinator
- The Chancellor Masters and Scholars of the University of Cambridge, United Kingdom
- Runs
- 1 September 2025 to 31 August 2027
- Status
- Running
- EU funding
- €260k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101206473
What the project is doing
In the project's own words, from its summary on CORDIS.
Fluorine offers unique properties that are invaluable in molecular design and discovery. Its importance is evidenced by theoverrepresentation of fluorine among synthetic small molecule therapeutics. However, unlike synthetic chemists, nature rarely uses fluorine as part of its design tools to construct bioactive molecules. To introduce fluorine into complex scaffolds such as natural products would offer enormous potential for accessing new structural space that combine beneficial features of biological and synthetic molecules for the discovery of novel functions.
This proposal, Bio-fluorine, aims to explore the incorporation of fluorine into terpenoids, which constitute the largest and most diverse class of natural products, using biosynthetic enzymes. The proposed research seeks to develop an entirely enzymatic pathway to incorporate fluorine from a simple precursor into diverse carbon skeletons. The proposed work also aims to develop a Saccharomyces cerevisiae chassis for scalable biological fluorine incorporation and novel organofluorine production.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| The Chancellor Masters and Scholars of the University of Cambridge | Cambridge | United Kingdom | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI